Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma

Hirsch,Dania; Levy,Sigal; Tsvetov,Gloria; Shimon,Ilan; Benbassat,Carlos

doi:10.3892/ol.2013.1765

Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma

Authors:
- Dania Hirsch
- Sigal Levy
- Gloria Tsvetov
- Ilan Shimon
- Carlos Benbassat
View Affiliations

Affiliations: Institute of Endocrinology, Rabin Medical Center, Beilinson Hospital, Petach Tikva 49100, Israel, Academic College of Tel Aviv‑Yaffo, Tel Aviv 6818211, Israel
Published online on: December 18, 2013 https://doi.org/10.3892/ol.2013.1765
Pages: 849-853

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The correct approach to treat low‑risk intrathyroidal papillary thyroid carcinoma (PTC) is controversial. Specific authors advocate unilateral thyroidectomy to minimize perioperative morbidity. The purpose of the present study was to determine an effective treatment strategy for patients with small unilateral papillary thyroid. This was a retrospective comparative analysis of 161 patients with PTC treated between 2001‑2010; 60 consecutive patients following hemithyroidectomy and 101 patients following total thyroidectomy. Only patients with preoperatively‑predicted localized unilateral disease were included. No between‑group difference was identified in the rate of permanent surgical complications. In total, 36 hemithyroidectomy patients (60%) exhibited benign thyroid nodules in the contralateral lobe on preoperative ultrasound; this factor was found to positively correlate with the performance of ≥1 fine needle aspirations (FNAs) during follow‑up. In addition, 47 hemithyroidectomy patients (78.3%) were prescribed thyroxine postoperatively. The hemithyroidectomy patients visited the endocrine clinic significantly less frequently than the total thyroidectomy patients (P=0.01), but were referred more often for neck ultrasound (P=0.03) and FNA (P<0.001). In addition, an increased number of patients in the hemithyroidectomy group were reoperated for suspected recurrent/persistent disease (P=0.06). Results of this retrospective study indicate that hemithyroidectomy for small unilateral PTC is associated with a significant follow‑up burden and provides no clear patient benefit.

View Figures

View References

1	Buckwalter JA and Thomas CG Jr: Selection of surgical treatment for well differentiated thyroid carcinomas. Ann Surg. 176:565–568. 1972. View Article : Google Scholar : PubMed/NCBI
2	Christensen SB, Ljungberg O and Tibblin S: Surgical treatment of thyroid carcinoma in a defined population: 1960 to 1979. Evaluation of the results after a conservative surgical approach. Am J Surg. 146:349–354. 1983.
3	Demeure MJ and Clark OH: Surgery in the treatment of thyroid cancer. Endocrinol Metab Clin North Am. 19:663–683. 1990.PubMed/NCBI
4	Friedman M and Pacella BL Jr: Total versus subtotal thyroidectomy: arguments, approaches and recommendations. Otolaryngol Clin North Am. 23:413–427. 1990.PubMed/NCBI
5	Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT and Page CP: Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore). 56:171–196. 1977. View Article : Google Scholar : PubMed/NCBI
6	Mazzaferri EL and Young RL: Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 70:511–518. 1981.PubMed/NCBI
7	Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS and Sturgeon C: Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 246:375–381. 2007. View Article : Google Scholar : PubMed/NCBI
8	Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19:1167–1214. 2009. View Article : Google Scholar
9	Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW and Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 154:787–803. 2006. View Article : Google Scholar : PubMed/NCBI
10	Shah MD, Witterick IJ, Eski SJ, Pinto R and Freeman JL: Quality of life in patients undergoing thyroid surgery. J Otolaryngol. 35:209–215. 2006. View Article : Google Scholar : PubMed/NCBI
11	Hoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA and Smit JW: Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 93:200–203. 2008. View Article : Google Scholar : PubMed/NCBI
12	Lee JI, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH and Kim SW: Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health Qual Life Outcomes. 8:1012010. View Article : Google Scholar : PubMed/NCBI
13	Esnaola NF, Cantor SB, Sherman SI, Lee JE and Evans DB: Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery. 130:921–930. 2001. View Article : Google Scholar : PubMed/NCBI
14	Shrime MG, Goldstein DP, Seaberg RM, Sawka AM, Rotstein L, Freeman JL and Gullane PJ: Cost-effective management of low-risk papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 133:1245–1253. 2007. View Article : Google Scholar : PubMed/NCBI
15	Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K and Miyauchi A: An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 13:381–387. 2003. View Article : Google Scholar
16	Siassakos D, Gourgiotis S, Moustafellos P, Dimopoulos N and Hadjiyannakis E: Thyroid microcarcinoma during thyroidectomy. Singapore Med J. 49:23–25. 2008.PubMed/NCBI
17	Mortensen JD, Woolner LB and Bennett WA: Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 15:1270–1280. 1955. View Article : Google Scholar : PubMed/NCBI
18	Ezzat S, Sarti DA, Cain DR and Braunstein GD: Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 154:1838–1840. 1994. View Article : Google Scholar : PubMed/NCBI
19	Udelsman R, Lakatos E and Ladenson P: Optimal surgery for papillary thyroid carcinoma. World J Surg. 20:88–93. 1996. View Article : Google Scholar
20	Marchesi M, Biffoni M, Faloci C, Biancari F and Campana FP: High rate of recurrence after lobectomy for solitary thyroid nodule. Eur J Surg. 168:397–400. 2002. View Article : Google Scholar : PubMed/NCBI
21	Hughes DT, Haymart MR, Miller BS, Gauger PG and Doherty GM: The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid. 21:231–236. 2011.